deptropine dihydrogen citrate manufacturers
|
| | deptropine dihydrogen citrate Basic information |
| Product Name: | deptropine dihydrogen citrate | | Synonyms: | deptropine dihydrogen citrate;B. S. 6987;Brontin;Brontina;Brontine;1-.alpha.-H,5-.alpha.-H-Triopane, 3-.alpha.-[(10,11-dihydro-5H-dibenzo[A,D]cyclohepten-5-yl)oxy]-, citrate (1:1);1.alpha.H,5.alpha.H-Tropane, 3.alpha.-[(10,11-dihydro-5H-dibenzo[A,D]cyclohepten-5-yl)oxy]-, citrate (1:1);3-.alpha.-[(10,11-Dihydro-5H-dibenzo[A,D]cyclohepten-5-yl)oxy]tropan dihydrogen citrate | | CAS: | 2169-75-7 | | MF: | C23H27NO.C6H8O7 | | MW: | 525.59 | | EINECS: | 2185161 | | Product Categories: | | | Mol File: | 2169-75-7.mol |  |
| | deptropine dihydrogen citrate Chemical Properties |
| Toxicity | LD50 in mice (mg/kg): 32 i.v.; 300 orally (Timmerman) |
| | deptropine dihydrogen citrate Usage And Synthesis |
| Chemical Properties | A white or almost white, microcrystalline powder, very slightly soluble in water and in ethanol, practically insoluble in methylene chloride. | | Uses | Histamine H1 receptor antagonist; anticholinergic. | | Definition | ChEBI: A citrate salt that is the dihydrogen citrate salt of deptropamine. | | Safety Profile | : A poison by ingestion,
intraperitoneal, intravenous route. When
heated to decomposition it emits toxic
vapors of NOx. |
| | deptropine dihydrogen citrate Preparation Products And Raw materials |
|